Multivalent DNA nanowire logic device coupled DNA Walker nanomachine for detecting membrane local marker, and preparation method and application of multivalent DNA nanowire logic device coupled DNA Walker nanomachine
Coupled DNA Walker nanomachines through multivalent DNA nanowire logic devices, the problem of insufficient signal amplification capability in the prior art is solved, and high sensitivity to local markers of cell membranes and simultaneous detection of multiple markers is achieved, especially in Effective detection in physiological environment.
Patent Information
- Application Number
- CN202411153179.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art lacks signal amplification ability when detecting local markers of cell membranes, especially in the physiological environment, and it is difficult to detect multiple markers at the same time, resulting in low detection sensitivity.
Using multivalent DNA nanowire logic device to couple DNA Walker nanomachines, the triangular prism structure and nucleic acid hybridization reaction are synthesized through PCR to form a DNAzyme chain with cholesterol. The logical chain anti-synthesis of substrate chains and multivalent DNA nanowires are cleaved using DNAzyme. , realize simultaneous detection and signal amplification of miRNA and membrane proteins.
High specificity and sensitivity detection of the interaction between miRNA released by cell damage and tumor cell CEM and immune cell NK are achieved, improving signal amplification ability and detection accuracy.
Smart Images

Figure CN119020468A_ABST
Abstract
Description
1. Technical Field
[0001] The present invention relates to the field of biomedicine technology, and in particular to a multivalent DNA nanowire logic device coupled DNA Walker nanomachine for detecting membrane localized markers, and a preparation method and application thereof. 2. Background Technology
[0002] Abnormal changes in local cell membrane markers are often closely related to the occurrence and development of diseases. For example, the occurrence and development of tumors are often accompanied by abnormal expression of certain proteins on the cell membrane; abnormal metabolites secreted by tumor cells will interact with surrounding cells, such as a significant increase in ADO, thereby inhibiting innate immune cells and T effector cells (CD 4+ and CD 8+ ) anti-tumor response. Therefore, the ability to detect these substances with high specificity and sensitivity is of great significance for disease analysis and personalized precision treatment. In addition, the methods for detecting membrane-localized markers in the current literature, such as aptamer switch conjugated hydrogel matrix and spatially selective recruitment of DNA amplicons, can detect membrane-localized markers on the membrane surface to a certain extent, but they all use single-stranded nucleic acid structures and have weak signal amplification effects. Considering the complex physiological environment on the cell membrane surface and the lack of signal amplification ability, the sensitivity of signal detection is low. At present, the commonly used amplification methods for detecting membrane-localized markers mainly rely on rolling circle amplification, hybridization chain reaction and CRISPR technology, but there are still some challenges that limit the application, for example: rolling circle amplification requires a specific buffer solution, which is not suitable for physiological environment. In addition, the current methods for detecting multiple markers simultaneously have insufficient logical output.
[0003] As a new biomaterial, DNA has many advantages as a biosensor in detecting localized markers of cell membranes, including high sensitivity, high specificity, versatility, real-time monitoring, and fluorescence amplification. DNAzyme is a DNA molecule with catalytic function that can catalyze certain chemical reactions under specific conditions. It is more stable than most protein enzymes, and has flexible design and wide application. It can be used as a signal amplification tool. DNAzyme has been successfully used as an amplification tool to detect and amplify protein and RNA signals. Using DNAzyme as a signal amplification tool on the membrane surface is a challenging attempt.
[0004] Aptamers are short, artificially synthesized single-stranded DNA or RNA molecules that can bind to target molecules with high specificity and affinity through their specific three-dimensional structures, and are therefore used for tumor diagnosis and treatment. In addition, DNA aptamers and DNA logic chains can form multivalent aptamer nanowires through base complementary pairing and DNA nanowires, which provide greatly enhanced cell binding selectivity, and enhanced stability and logic operation output, thereby achieving increased output of multiple membrane proteins on tumor cells at the same time. Using aptamers combined with logic chains to detect multiple membrane protein signals has been successfully used to specifically identify cells. How to enhance the signal output of DNA logic chains is a technical problem that needs to be solved urgently. III. Summary of the invention
[0005] In view of the above situation, in order to solve the defects of the prior art, the purpose of the present invention is to provide a multivalent DNA nanowire logic device coupled with a DNA Walker nanomachine for detecting membrane localized markers, and its preparation method and application, which can effectively detect miRNA released by cell damage and specifically identify cells and the interaction between tumor cells CEM and immune cells NK.
[0006] The technical solution provided by the present invention is that in the multivalent DNA nanowire logic device coupled to the DNA Walker nanomachine (DNA Walker Device, DWD) for detecting membrane localized markers, the main frame of the DNA Walker nanomachine is a triangular prism (TP) structure synthesized by PCR, the lower end of the TP structure contains three nucleic acid chains with cholesterol, and the upper end contains a DNAzyme chain combined with a Block chain and two substrate chains. When liver cells are damaged and release miRNA122, miRNA122 will bind to the Block chain, and the released DNAzyme will be released in the Ca 2+ The substrate chain will be cut under the action of the CEM to detect the localized membrane markers; the multivalent DNA nanowire is a hybrid chain anti-synthesized by a trigger chain (Trigger), two hairpin chains H1 and H2, and the complementary chain nucleic acid aptamer chain of H1 and the complementary chain logic chain of H2. The two multivalent DNA nanowires connected with different aptamer chains and logic chains can realize the AND gate logic output for simultaneous detection of two membrane proteins. The output logic chain can open the DNAzyme for signal amplification to realize the detection of specific cells; finally, the multivalent DNA nanowire is specifically connected to the logic chain output by the CEM, which can open the DNA Walker nanomachine connected to the NK to realize the detection of tumor cells CEM and immune cells NK.
[0007] The method for preparing a multivalent DNA nanowire logic device coupled with a DNA Walker nanomachine for detecting membrane localized markers of the present invention comprises the following steps:
[0008] 1) PCR reaction: Dissolve the three chains S1, S2, and S3 of the synthesized TP in a buffer solution, add S1, S2, and S3 to a PCR tube, mix well, centrifuge, and place in a PCR module to obtain a TP solution;
[0009] The S1 sequence is: TCGCTGAGTATTTTCCACCACCAAACCACATTTGTTTTGCAAGTGTGGGCACGCACACTTTTCGCACCGCGACTGCGAGGACTTTTCACAAATCTG, as shown in SEQ ID NO.1;
[0010] The sequence of S2 is: CACTGGTCAGTTTTCCACCACCAAACCACATTTGTTTTTACTCAGCGACAGATTTGTGTTTTCGCACCGCGACTGCGAGGACTTTTGGTTTGCTGA, as shown in SEQ ID NO.2;
[0011] The sequence of S3 is: CCACACTTGCTTTTCAACCCACAATCCCAGTGTGTTTTCTGACC AGTGTCAGCAAACCTTTTCGCACCGCGACTGCGAGGACTTTTGTGTGCGTGC, as shown in SEQ ID NO.3;
[0012] The buffer solution is composed of Tris (0.12 g), MgCl2 (0.06 g), EDTA2Na (0.037 g) and ddH2O (50 mL), with a pH of 7.4;
[0013] 2) DWD nucleic acid hybridization reaction: add cholesterol nucleic acid chain, DNAzyme and Block chain to the TP solution synthesized by PCR in step 1), mix, centrifuge, react at room temperature to obtain DWD without substrate chain, add substrate chain, mix, centrifuge, react at room temperature to obtain DWD with substrate chain;
[0014] The cholesterol nucleic acid chain sequence is: GTCCTCGCAGTCGCGGTGCGTTTTTTTTTT-chol, as shown in SEQ ID NO.4;
[0015] The DNAzyme sequence is: CACACTGGGATTGTGG tttttttttttttttttttttttAAACATCTTCTCT
[0016] CAGCGAGACGAAATGGAGTGTGA-cy5, as shown in SEQ ID NO.5;
[0017] The Block sequence is: CAAACACCATT-BHQ2GTCACACTCCATTTCGT, as shown in SEQ ID NO.6;
[0018] The substrate strand sequence is: CAC / T-BHQ2 / CCAT / rA / GGA-cy5-AGATGGCGAAA ttttttttttttttttttttttGTGGTTTGGTGGTGG, as shown in SEQ ID NO.7;
[0019] 3) DNAzyme substrate cleavage reaction: The DWD without substrate chain and the DWD with substrate chain prepared in step 2) were incubated with CEM cells at room temperature, centrifuged, the supernatant was removed, and the mixture was resuspended in PBS. The miRNA122 chain and Ca 2+ and Mg 2+ , react at room temperature, and obtain DNA Walker nanomachines without substrate chains and DNA Walker nanomachines with substrate chains;
[0020] The miRNA122 sequence is: TGGAGTGTGACAATGGTGTTTG, as shown in SEQ ID NO.8;
[0021] 4) Hybridization chain synthesis of nanowires: H1 and H2 are annealed to form a hairpin structure, and then the Trigger chain is added to H1, H2, H1-Sgc8, and H2-FAM respectively, mixed, centrifuged, and reacted at room temperature to obtain multivalent DNA nanowires;
[0022] The Trigger sequence is: ACGGCTTGCTGCTGCTGCTGCTGC, as shown in SEQ ID NO.9;
[0023] The H1 sequence is: GACGTGCAGGCTGTGCTGCTGCTGCTGCTGCACGACGGCAGCAGCAGCAGCAGCAAGCCGT, as shown in SEQ ID NO.10;
[0024] The H2 sequence is: CGTCGTGCAGCAGCAGCAGCAGCAACGGCTTGCTGCTGCTGCTGCTGCGTGAGCACGGACG, as shown in SEQ ID NO.11;
[0025] The H1-Sgc8 aptamer sequence is: CAGCCTGCACGTCttttttttttttttttATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA, as shown in SEQ ID NO.12;
[0026] The H2-FAM sequence is: FAM-GCGCACGCGTGCCGACGGCCTTTTTTTTTTTCGTCCGTGCTCAC, as shown in SEQ ID NO.13;
[0027] 5) Logical nucleic acid chain hybridization reaction: Incubate the DNA Walker nanomachine with substrate chain prepared in step 3) with CEM cells at room temperature, centrifuge, remove supernatant, resuspend with PBS, add the multivalent DNA nanowires prepared in step 4) respectively binding to H2-TCO1, H1-connect and binding to H1-Sgc8, H2-connect, incubate at room temperature, centrifuge, remove supernatant, resuspend with PBS, add connect, Ca 2+ and Mg 2+ , to achieve the detection of tumor cell CEM and immune cell NK;
[0028] The H1-Sgc8 sequence is: CAGCCTGCACGTCtttttttttttttttATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA, as shown in SEQ ID NO.14;
[0029] The H2-TCO1 sequence is: ACCAAACACAGATGCAACCTGACTTCTAACGTCATTTGGTttttttttttttttttCGTCCGTGCTCAC, as shown in SEQ ID NO.15;
[0030] The H1-connect sequence is: CAGCCTGCACGTCTTTTTTTTTTTTTTTCGACATCTAACCTGGACAATGGTGTTTG, as shown in SEQ ID NO.16;
[0031] The H2-connect sequence is: ACGAAATGGAGTGTGGCTCACTGACGCTAGGTTTTTTTTTTTTTCGTCCGTGCTCAC, as shown in SEQ ID NO.17;
[0032] The connect sequence is: CTTACAACACCTAGCGTCAGTGAGCCCAGGTTAGATGTCG, as shown in SEQ ID NO.18.
[0033] The DNA Walker nanomachine and the multivalent DNA nanowire of the present invention present triangular prism and linear structures respectively, have certain rheological properties, and are beneficial to the survival of cells.
[0034] The CEM cells described in the present invention belong to acute T lymphocytic leukemia, which is a highly invasive blood cancer.
[0035] The invention discloses an application of a multivalent DNA nanowire logic device coupled with a DNA Walker nanomachine for detecting membrane localized markers in the preparation of a kit for detecting miRNA122 released by liver damage.
[0036] The invention discloses an application of a multivalent DNA nanowire logic device coupled with a DNA Walker nanomachine for detecting membrane localized markers in the preparation of a kit for specifically identifying and detecting tumor cells.
[0037] The preparation method of the present invention is simple and easy to operate. The nucleic acid chain, DNAzyme and substrate chain connected with cholesterol are modified by PCR synthesis of TP structure and nucleic acid hybridization reaction to realize in situ amplification sensing, which is suitable for detecting miRNA released by liver injury. The multivalent nanowires combined with modified nucleic acid aptamers and logic chains are suitable for specific cell recognition and detection of the interaction between tumor cells and immune cells. It has a wide range of applications and significant economic and social benefits. IV. Description of the drawings
[0038] Figure 1 Schematic diagram of the principle of the DNA Walker nanomachine and multivalent DNA nanowire prepared in the present invention.
[0039] Figure 2 Atomic force microscopy images and analysis of the DNA Walker nanomachine and multivalent DNA nanowires of the present invention.
[0040] Figure 3 This is the activation DNAzyme cleavage activity diagram based on the nucleic acid chain logic operation output of Experiment 1 of the present invention.
[0041] Figure 4 This is a diagram of the investigation of DWD anchoring outside the cell membrane in Experiment 2 of the present invention.
[0042] Figure 5 This is a diagram for investigating the universality and safety of DWD anchoring in cells in Experiment 3 of the present invention.
[0043] Figure 6This is a graph investigating the effect of membrane fluidity on the amplification of DNAzyme cleavage substrate in Experiment 4 of the present invention.
[0044] Figure 7 This is a graph of miRNA122 released by liver injury detected by DWD in Experiment 5 of the present invention.
[0045] Figure 8 This is a diagram of the specific recognition of CEM cells by the multivalent DNA nanowire-coupled DNA Walker nanomachine in Experiment 6 of the present invention.
[0046] Fig. 9 This is a graph of the miRNA signal detection in response to comparative experiment 1 of the present invention using a substrate-free chain.
[0047] Fig.10 This is a graph showing the investigation of the binding ability of monovalent nanowires in comparative experiment 2 of the present invention. V. Specific implementation methods
[0048] The specific implementation of the present invention is further described in detail below in conjunction with the accompanying drawings and examples.
[0049] Example 1
[0050] The present invention, when implemented, specifically comprises the following steps:
[0051] 1) PCR reaction: Dissolve the three chains S1, S2, and S3 of the synthetic TP in buffer to 2 μM (except for the cholesterol chain which is dissolved in DEPC, the rest are dissolved in buffer), take 1 μL of S1, S2, and S3 respectively and add them to a 200 μL PCR tube, mix well, centrifuge, and put into the PCR module. The program is as follows: annealing includes 95°C constant for 5 min; 5 cycles, 1 min per cycle, with a gradient temperature drop of 1°C; 30 cycles, 1 min per cycle, with a gradient temperature drop of 0.4°C; 70 cycles, 1 min per cycle, with a gradient temperature drop of 0.8°C; 22°C constant for 30 min, and then put into a 4°C refrigerator for 1 h to obtain the TP solution;
[0052] The S1 sequence is: TCGCTGAGTATTTTCCACCACCAAACCACATTTGTTTTGCAAGTGTGGGCACGCACACTTTTCGCACCGCGACTGCGAGGACTTTTCACAAATCTG, as shown in SEQ ID NO.1;
[0053] The sequence of S2 is: CACTGGTCAGTTTTCCACCACCAAACCACATTTGTTTTTACTCAGCGACAGATTTGTGTTTTCGCACCGCGACTGCGAGGACTTTTGGTTTGCTGA, as shown in SEQ ID NO.2;
[0054] The sequence of S3 is: CCACACTTGCTTTTCAACCCACAATCCCAGTGTGTTTTCTGACCAGTGTCAGCAAACCTTTTCGCACCGCGACTGCGAGGACTTTTGTGTGCGTGC, as shown in SEQ ID NO.3;
[0055] The buffer solution is composed of Tris (0.12 g), MgCl2 (0.06 g), EDTA2Na (0.037 g) and ddH2O (50 mL), with a pH of 7.4;
[0056] 2) DWD nucleic acid hybridization reaction: add 3 μL of 2 μM cholesterol nucleic acid chain, 1 μL of 2 μM DNAzyme and 1 μL of 2 μM Block chain to the 3 μL TP solution synthesized by PCR in step 1), mix well, centrifuge, react at room temperature for 1 hour to obtain DWD without substrate chain, add 2 μL of 2 μM substrate chain, mix well, centrifuge, react at room temperature for 1 hour to obtain DWD with substrate chain;
[0057] The cholesterol nucleic acid chain sequence is: GTCCTCGCAGTCGCGGTGCGTTTTTTTTTT-chol, as shown in SEQ ID NO.4;
[0058] The DNAzyme sequence is: CACACTGGGATTGTGG tttttttttttttttttttttttAAACATCTTCTCT
[0059] CAGCGAGACGAAATGGAGTGTGA-cy5, as shown in SEQ ID NO.5;
[0060] The Block sequence is: CAA ACACCATT-BHQ2GTCACACTCCATTTCGT, as shown in SEQ ID NO.6;
[0061] The substrate strand sequence is: CAC / T-BHQ2 / CCAT / rA / GGA-cy5-AGATGGCGAAA ttttttttttttttttttttttGTGGTTTGGTGGTGG, as shown in SEQ ID NO.7;
[0062] 3) DNAzyme substrate cleavage reaction: DWD without substrate chain and DWD with substrate chain prepared in step 2) with a volume of 1 μL and a concentration of 2 μM were mixed with 2×10 5 After incubation at room temperature for 30 min, CEM cells were centrifuged at 1500 rpm for 3 min, the supernatant was removed, and 100 μL of PBS was resuspended. 20 nM miRNA122 strand, 2.5 mM Ca 2+ and 1.25 mM Mg 2+ , react at room temperature for 2 hours, and obtain DNA Walker nanomachines without substrate chains and DNA Walker nanomachines with substrate chains;
[0063] The miRNA122 sequence is: TGGAGTGTGACAATGGTGTTTG, as shown in SEQ ID NO.8;
[0064] 4) Hybridization chain synthesis nanowire reaction: 5 μL H1 and H2 were annealed to form a hairpin structure. The annealing procedure was as follows: 95°C for 10 min, then immediately placed in ice for 30 min, and finally placed at room temperature for 2 h. Then, 0.2 μM and 1 μL of the Trigger chain were added with 2 μM and 1 μL of H1, H2, H1-Sgc8, and H2-FAM, respectively, and mixed. The mixture was centrifuged and reacted at room temperature for 3 h to prepare a multivalent DNA nanowire with Trigger:H1:H2=1:10:10;
[0065] The Trigger sequence is: ACGGCTTGCTGCTGCTGCTGCTGC, as shown in SEQ ID NO.9;
[0066] The H1 sequence is: GACGTGCAGGCTGTGCTGCTGCTGCTGCTGCACGACGGCAGCAGCAGCAGCAGCAAGCCGT, as shown in SEQ ID NO.10;
[0067] The H2 sequence is: CGTCGTGCAGCAGCAGCAGCAGCAACGGCTTGCTGCTGCTGCTGCTGCGTGAGCACGGACG, as shown in SEQ ID NO.11;
[0068] The H1-Sgc8 aptamer sequence is: CAGCCTGCACGTCttttttttttttttttATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA, as shown in SEQ ID NO.12;
[0069] The H2-FAM sequence is: FAM-GCGCACGCGTGCCGACGGCCTTTTTTTTTTTCGTCCGTGCTCAC, as shown in SEQ ID NO.13;
[0070] 5) Logical nucleic acid chain hybridization reaction: The DNAWalker nanomachine with a volume of 1 μL and a concentration of 2 μM prepared in step 3) and 2×10 5 After incubating the CEM cells at room temperature for 30 min, centrifuge at 1500 rpm for 3 min, remove the supernatant, resuspend the cells in PBS to 100 μL, add 1 μL of 2 μM multivalent DNA nanowires prepared in step 4) that bind to H2-TCO1, H1-connect, and bind to H1-Sgc8, H2-connect, incubate the cells at room temperature for 30 min, centrifuge at 1500 rpm for 3 min, remove the supernatant, resuspend the cells in PBS to 100 μL, add 2 μM connect, 2.5 mM Ca 2+ and 1.25 mM Mg 2+ , react at 37℃ for 2h to detect tumor cell CEM and immune cell NK;
[0071] The H1-Sgc8 sequence is: CAGCCTGCACGTCtttttttttttttttATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA, as shown in SEQ ID NO.14;
[0072] The H2-TCO1 sequence is: ACCAAACACAGATGCAACCTGACTTCTAACGTCATTTGGTttttttttttttttttCGTCCGTGCTCAC, as shown in SEQ ID NO.15;
[0073] The H1-connect sequence is: CAGCCTGCACGTCTTTTTTTTTTTTTTTCGACATCTAACCTGGACAATGGTGTTTG, as shown in SEQ ID NO.16;
[0074] The H2-connect sequence is: ACGAAATGGAGTGTGGCTCACTGACGCTAGGTTTTTTTTTTTTTCGTCCGTGCTCAC, as shown in SEQ ID NO.17;
[0075] The connect sequence is: CTTACAACACCTAGCGTCAGTGAGCCCAGGTTAGATGTCG, as shown in SEQ ID NO.18.
[0076] The basic principle of the present invention is that the main framework of DWD is a TP structure synthesized by PCR, with three nucleic acid chains with cholesterol at the lower end, and a DNAzyme chain and two substrate chains combined with the Block chain at the upper end. The design can effectively sense miRNA122, and amplify the signal by cutting the substrate with DNAzyme, so as to achieve early detection of liver damage, and can respond promptly and efficiently in situ. The multivalent DNA nanowire is a hybrid chain anti-synthesis of the trigger chain (Trigger) and two hairpin chains H1 and H2, as well as the complementary nucleic acid aptamer chain of H1 and the complementary logic chain of H2. The two multivalent DNA nanowires connected with different aptamers and logic chains can realize the AND gate logic output of the simultaneous detection of two membrane proteins. By using PTK7 (protein tyrosine kinase 7) and TNC (tumor necrosis factor) highly expressed in tumor cell CEM, the multivalent nanowires are specifically bound to tumor cells, so that the logic nucleic acid outputs a specific opening sequence, thereby activating the cutting activity of DNAzyme and generating a fluorescent signal, thereby realizing the detection of specific cells and cell-to-cell interactions.
[0077] The multivalent DNA nanowire logic device and DWD prepared by the method of the present invention for detecting miRNA released by cell damage and specifically identifying the interaction between cells and tumor cells CEM and immune cells NK have been verified by experiments to be very effective. Taking Example 1 as an example, the quantitative tests in the following experiments are all repeated three times, and the results are averaged. The experimental methods used in the experiments are all conventional methods unless otherwise specified. Unless otherwise specified, the experimental materials, reagents and equipment in the embodiments can be obtained through conventional purchasing channels. The relevant experimental data are as follows:
[0078] Experiment 1: Activating DNAzyme cleavage activity based on nucleic acid chain logic operation output
[0079] The two nucleic acid chains will logically output a chain with a specific sequence under the action of the connect chain. This chain can combine with the block chain and release DNAzyme. DNAzyme is in physiological Ca 2+ and Mg 2+Under these conditions, the substrate chain will be further cut to generate a new product chain, such as the bottom band of lane 5. Specifically, 1 μL of Block and DNAzyme with a concentration of 2 μM was first added to 200 μL tubes numbered 2, 3, 4, and 5 for reaction for 1 hour, and then 2 μL of substrate chain with a concentration of 2 μM was added to tubes 1-5, 1 μL of H1-connect chain with a concentration of 2 μM was added to tube 3, 1 μL of H2-connect chain with a concentration of 2 μM was added to tube 4, 1 μL of H1-connect and 1 μL of H2-connect chain with a concentration of 2 μM was added to tube 5, and 1 μL of connect chain with a concentration of 2 μM was added to tubes 3-5, and Ca was added to each tube. 2+ and Mg 2+ The concentrations were 2.5mM and 1.25mM respectively, and the volume was fixed to 10μL with DEPC. H1-connect, H2-connect and connect chains will form open chains, releasing the activity of DNAzyme, and then cutting the substrate chain. After reacting at 37℃ for 2h, polyacrylamide gel electrophoresis was performed. The structure was as follows Figure 3 As shown in a. The corresponding fluorescence experiment is consistent with the experimental steps of 3a, but the nucleic acid chains are all fluorescently modified, where DNAzyme is modified with Cy5, Block is modified with BHQ2, and the substrate chain is modified with Cy5 and BHQ2. Under the condition of no chain opening, Cy5 is quenched by BHQ. Under the condition of chain opening, the activity of DNAzyme is released, and then the substrate chain is cut to produce Cy5 fluorescence value, as shown in Figure 3 As shown in b.
[0080] Experiment 2: DWD anchored outside the cell membrane
[0081] DWD without cholesterol, DWD, DWD plus exonuclease, DWD plus displacement strand, and 2×10 5 CEM cells were incubated. Specific steps: DWD without cholesterol, DWD group and cells were incubated for 30 minutes, centrifuged at 1500rpm for 3 minutes, supernatant was removed, and 200μL was resuspended in PBS. DWD plus exonuclease and DWD plus displacement chain group needed to be incubated with DWD and cells at room temperature for 30 minutes, centrifuged at 1500rpm for 3 minutes, supernatant was removed, 100μL was resuspended in PBS, and then 12μL of exonuclease, 31μL of exonuclease and 10μM fluorescent chain were added respectively. The corresponding confocal and flow structures are shown in 4a and 4b.
[0082] Experiment 3: Investigation of the universality and safety of DWD anchoring in cells
[0083] The volume of 1 μL and the concentration of 2 μM DWD were anchored at 2×10 5Ramos and HepG2 were incubated for 30 min, and the confocal results are shown in 5a; 2 μM and 20 μM DWD were prepared and 1×10 4 CEM and HepG2 were incubated, PBS was added to 100 μL, and the blank group was placed in the cell culture incubator under the same conditions for 24 hours before the CCK8 experiment was performed. The results are shown in 5b.
[0084] Experiment 4: Effect of membrane fluidity on the amplification of DNAzyme substrate cleavage
[0085] Take two tubes of 2×10 5 After incubation of 1 μL CEM and 2 μM DWD at room temperature for 30 min, centrifuge at 1500 rpm for 3 min, and remove the supernatant. Add 70 μL paraformaldehyde to tube 1 for 10 min, centrifuge at 1500 rpm for 3 min, remove the supernatant, resuspend both tubes in PBS to 100 μL, add 2 μM open chain, 2.5 mM Ca 2+ and 1.25 mM Mg 2+ After 2 h of reaction at room temperature, the fluorescence effect of the flow cell membrane was significantly stronger than that of the fixed group, indicating that membrane flow has a significant effect on DNAzyme cleavage substrates. Figure 6 shown.
[0086] Experiment 5: DWD detection of miRNA122 released by liver injury
[0087] Take two tubes of 2×10 5 After incubating each HepG2 cell with 1 μL DWD at 2 μM at room temperature for 30 min, the cells were centrifuged at 1500 rpm for 3 min, and the supernatant was removed. Electroporation was performed in tube 2, which was centrifuged at 1500 rpm for 3 min, and the supernatant was removed. The cells were resuspended to 10 μL with electroporation buffer. The electroporation parameters were: pulse voltage 1230 V, pulse width 20 ms, and pulse number 3. The two groups of cells were resuspended in 100 μL PBS, and 2.5 mM Ca was added. 2+ and 1.25 mM Mg 2+ , 37℃ for 2h. The fluorescence signal of the electrical injury group was significantly stronger than that of the control group. Figure 7 As shown in a.
[0088] Take two tubes of 2×10 5 After incubating 1 μL of HepG2 cells with 2 μM DWD at room temperature for 30 min, the cells were centrifuged at 1500 rpm for 3 min, and the supernatant was removed. The alcohol injury experiment was performed on tube 2, which was centrifuged at 1500 rpm for 3 min, the supernatant was removed, and the cells were resuspended in 40% alcohol to 100 μL. The cells in tube 1 were resuspended in PBS to 100 μL, and Ca was added to both tubes. 2+ and Mg 2+The concentrations were 2.5 mM and 1.25 mM, respectively, and the reaction was carried out at 37°C for 2 h. The fluorescence signal of the alcohol injury group was significantly stronger than that of the control group. Figure 7 b. This suggests that DWD can detect miRNA122 released by liver injury.
[0089] Experiment 6: Multivalent DNA nanowire-coupled DNAWalker nanomachine specifically recognizes CEM cells
[0090] Two types of multivalent nanowires were prepared, one combining Sgc8 and H1-connection and the other combining TCO1 and H2-connection. Four tubes of 2 × 10 5 CEM, resuspended to 100 μL with PBS and 1 μL of DWD at a concentration of 2 μM, incubated at room temperature for 30 min, centrifuged at 1500 rpm for 3 min, removed the supernatant, and resuspended to 100 μL with PBS. Tube No. 2 added 1 μL of multivalent nanowires binding to TCO1 at a concentration of 2 μM, tube No. 3 added 1 μL of multivalent nanowires binding to Sgc8 at a concentration of 2 μM, and tube No. 4 added 1 μL of multivalent nanowires binding to TCO1 and Sgc8 at a concentration of 2 μM, incubated at room temperature for 30 min, centrifuged at 1500 rpm for 3 min, and removed the supernatant. Resuspended to 100 μL with PBS, added 2 μM connect, 2.5 mM Ca to each tube 2+ and 1.25 mM Mg 2+ , react at 37℃ for 2h. Only when two aptamer chains exist at the same time can the fluorescent signal be generated. Figure 8 As shown in a.
[0091] Then, 1 μL of DWD and 2×10 5 After incubating Ramos and 293T at room temperature for 30 minutes, centrifuge at 1500 rpm for 3 minutes, remove the supernatant, and resuspend in PBS to 100 μL. Add 1 μL of multivalent nanowires binding to TCO1 and Sgc8 at a concentration of 2 μM, incubate at room temperature for 30 minutes, centrifuge at 1500 rpm for 3 minutes, and remove the supernatant. Resuspend in PBS to 100 μL, add 2 μM connect, 2.5 mM Ca 2+ and 1.25 mM Mg 2+ , reacted at 37℃ for 2h, both cells showed fluorescence shift, such as Figure 8 As shown in b.
[0092] Comparative experiment 1: Using substrate-free chain to detect miRNA signal response
[0093] The volume of 1 μL, concentration of 2 μM DWD, and 2×10 5After incubation at room temperature for 30 min, the CEM cells were centrifuged at 1500 rpm for 3 min, the supernatant was removed, and 100 μL of PBS was used to resuspend the cells. 2+ and Mg 2+ The concentrations were 2.5 mM and 1.25 mM, respectively. After reacting at room temperature for 2 h, the fluorescence effect of DWD with substrate chains was significantly stronger than that without substrate chains, indicating that the amplification effect of DNAzyme on substrate cleavage was significant. Fig. 9 shown.
[0094] Comparative experiment 2: Investigation of binding ability using monovalent nanowires
[0095] 1 μL of 2 μM and 0.2 μM Trigger chains were added to 1 μL of 2 μM H1, H2, H1-Sgc8, and H2-FAM at room temperature for 3 h to prepare Trigger: H1: H2 = 1: 1: 1 and 1: 10: 10, respectively, and 2 × 10 5 The CEM was incubated at room temperature for 30 min, and the confocal results are shown in 10a. The multivalent nanowires have stronger binding ability.
[0096] Trigger: H1:H2 = 1:1:1 and 1:10:10 were incubated with or without 10% serum at 37°C or 4°C for 30 min, and the results are shown in 10b. The multivalent nanowires have stronger binding ability under complex conditions.
[0097] It can be seen from the above that the preparation method of the present invention is simple and easy to operate, and has the following advantages compared with the prior art:
[0098] 1. The present invention utilizes DNA technology to encode a multifunctional nucleic acid template sequence, forms a TP structure by PCR, and then simply self-assembles to form a DWD, thus avoiding complex design and synthesis;
[0099] 2. The present invention is suitable for early detection of liver damage. Compared with the problems of insufficient sensitivity and low utilization rate of nucleic acid chains in blood testing or spatially selectively recruited DNA amplicons, the DWD has higher sensitivity, timeliness and in-situ safety detection;
[0100] 3. The present invention utilizes the high expression of PTK7 (protein tyrosine kinase 7) and TNC (tumor necrosis factor) in tumor cell CEM, so that the multivalent nanowires specifically bind to the tumor cell CEM, so that the logic nucleic acid outputs a specific opening sequence, thereby activating the cutting activity of DNAzyme and generating a fluorescent signal, thereby realizing the detection of specific cells and cell-to-cell interactions.
[0101] 4. The present invention is suitable for detecting a variety of membrane localized markers, such as miRNA122, membrane proteins, and interactions with specific cells;
[0102] 5. By encoding different functional sequences, the present invention also has the versatility and simplicity of design for other miRNA- and membrane protein-based aptamers, such as miRNA21, Xq2d aptamer, PD1 aptamer, etc. It has a wide range of applications and significant economic and social benefits.
[0103] It should be pointed out that the above is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any technician familiar with the profession can make changes or modify the technical contents disclosed above into equivalent embodiments with equivalent changes without departing from the scope of the technical solution of the present invention, which all fall within the protection scope of the present invention.
Claims
1. A multivalent DNA nanowire logic device coupled with a DNA Walker nanomachine for detecting membrane-localized markers, It is characterized in that The main framework of the DNA Walker nanomachine is a triangular prism structure synthesized by PCR. The lower end of the triangular prism structure contains three nucleic acid chains with cholesterol, and the upper end contains a DNAzyme chain bound to the Block chain and two substrate chains. When liver cells are damaged and release miRNA122, miRNA122 will bind to the Block chain, and the released DNAzyme will be released in Ca 2+ The substrate chain will be cut under the action of the substrate chain to realize the detection of membrane localized markers; the multivalent DNA nanowire is a hybrid chain anti-synthesized by the initiator chain, two hairpin chains H1 and H2, the complementary chain nucleic acid aptamer chain of H1, and the complementary chain logic chain of H2. The two multivalent DNA nanowires connected with different aptamer chains and logic chains can realize the AND gate logic output for simultaneous detection of two membrane proteins. The output logic chain can open the DNAzyme for signal amplification to realize the detection of specific cells; finally, the multivalent DNA nanowire is specifically connected to the logic chain output by the CEM, which can open the DNA Walker nanomachine connected to the NK to realize the detection of tumor cells CEM and immune cells NK.
2. The method for preparing the multivalent DNA nanowire logic device coupled with the DNAWalker nanomachine for detecting membrane localized markers according to claim 1, It is characterized in that The following steps are involved: 1) PCR reaction: Dissolve the three chains S1, S2, and S3 of the synthesized TP in a buffer solution, add S1, S2, and S3 to a PCR tube, mix well, centrifuge, and place in a PCR module to obtain a TP solution; The S 1 The sequence is: TCGCTGAGTATTTTCCACCACCAAACCACATTTGTTTTGCAAGTGT GGGCACGCACACTTTTCGCACCGCGACTGCGAGGACTTTTCACAAATCTG, as shown in SEQ ID NO.1; The S 2 The sequence is: CACTGGTCAGTTTTCCACCACCAAACCACATTTGTTTTTACTCAG CGACAGATTTGTGTTTTTCGCACCGCGACTGCGAGGACTTTTGGTTTGCTGA, as shown in SEQ ID NO.2; The S 3 The sequence is: CCACACTTGCTTTTCAACCCACAATCCCAGTGTGTTTTCTGACC AGTGTCAGCAAACCTTTTCGCACCGCGACTGCGAGGACTTTTGTGTGCGTGC, as shown in SEQ ID NO.3; The buffer composition is: Tris 0.12g, MgCl 2 0.06 g, EDTA2Na 0.037 g and ddH 2 O 50mL, pH 7.4; 2) DWD nucleic acid hybridization reaction: add cholesterol nucleic acid chain, DNAzyme and Block chain to the TP solution synthesized by PCR in step 1), mix, centrifuge, react at room temperature to obtain DWD without substrate chain, add substrate chain, mix, centrifuge, react at room temperature to obtain DWD with substrate chain; The cholesterol nucleic acid chain sequence is: GTCCTCGCAGTCGCGGTGCGTTTTTTTTTT-chol, as shown in SEQ ID NO.4; The DNAzyme sequence is: CACACTGGGATTGTGG tttttttttttttttttttttttt AAACATCTTCTCT CAGCGAGACGAAATGGAGTGTGA-cy5, as shown in SEQ ID NO.5; The Block sequence is: CAA ACACCATT-BHQ2GTCACACTCCATTTCGT, as shown in SEQ ID NO.6; The substrate strand sequence is: CAC / T-BHQ2 / CCAT / rA / GGA-cy5-AGATGGCGAAA ttttttttttttttttttttttGTGGTTTGGTGGTGG, as shown in SEQ ID NO.7; 3) DNAzyme substrate cleavage reaction: The DWD without substrate chain and the DWD with substrate chain prepared in step 2) were incubated with CEM cells at room temperature, centrifuged, the supernatant was removed, and the mixture was resuspended in PBS. The miRNA122 chain and Ca 2+ and Mg 2+ , react at room temperature, and obtain DNAWalker nanomachines without substrate chains and DNAWalker nanomachines with substrate chains; The miRNA122 sequence is: TGGAGTGTGACAATGGTGTTTG, as shown in SEQ ID NO.8; 4) Hybridization chain synthesis of nanowires: H1 and H2 are annealed to form a hairpin structure, and then the Trigger chain is added to H1, H2, H1-Sgc8, and H2-FAM respectively, mixed, centrifuged, and reacted at room temperature to obtain multivalent DNA nanowires; The Trigger sequence is: ACGGCTTGCTGCTGCTGCTGCTGC, as shown in SEQ ID NO.9; The H1 sequence is: GACGTGCAGGCTGTGCTGCTGCTGCTGCTGCACGACGGCAGCAGCAGCAGCAGCAAGCCGT, as shown in SEQ ID NO.10; The H2 sequence is: CGTCGTGCAGCAGCAGCAGCAGCAACGGCTTGCTGCTGCTGCTGCTGCGTGAGCACGGACG, as shown in SEQ ID NO.11; The H1-Sgc8 aptamer sequence is: CAGCCTGCACGTCttttttttttttttttATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA, as shown in SEQ ID NO.12; The H2-FAM sequence is: FAM-GCGCACGCGTGCCGACGGCCTTTTTTTTTTTCGTCCG TGCTCAC, as shown in SEQ ID NO.13; 5) Logical nucleic acid chain hybridization reaction: Incubate the DNAWalker nanomachine with substrate chain prepared in step 3) and CEM cells at room temperature, centrifuge, remove the supernatant, resuspend in PBS, add the multivalent DNA nanowires prepared in step 4) respectively binding to H2-TCO1, H1-connect and binding to H1-Sgc8, H2-connect, incubate at room temperature, centrifuge, remove the supernatant, resuspend in PBS, add connect, Ca 2+ and Mg 2+ , to achieve the detection of tumor cell CEM and immune cell NK; The H1-Sgc8 sequence is: CAGCCTGCACGTCtttttttttttttttATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA, as shown in SEQ ID NO.14; The H2-TCO1 sequence is: ACCAAACACAGATGCAACCTGACTTCTAACGTCATTTGGTttttttttttttttttCGTCCGTGCTCAC, as shown in SEQ ID NO.15; The H1-connect sequence is: CAGCCTGCACGTCTTTTTTTTTTTTTTTCGACATCTAACCTGGACAATGGTGTTTG, as shown in SEQ ID NO.16; The H2-connect sequence is: ACGAAATGGAGTGTGGCTCACTGACGCTAGGTTTTTTTTTTTTTCGTCCGTGCTCAC, as shown in SEQ ID NO.17; The connect sequence is: CTTACAACACCTAGCGTCAGTGAGCCCAGGTTAGATGTCG, as shown in SEQ ID NO.
18.
3. The method for preparing a multivalent DNA nanowire logic device coupled with a DNAWalker nanomachine for detecting membrane localized markers according to claim 2, It is characterized in that The specific steps include: 1) PCR reaction: Dissolve the three chains S1, S2, and S3 of the synthetic TP in buffer to 2 μM, take 1 μL of S1, S2, and S3 respectively and add them to a 200 μL PCR tube, mix well, centrifuge, and put into the PCR module. The program is as follows: annealing includes 95°C constant for 5 min; 5 cycles, each cycle for 1 min, with a gradient temperature drop of 1°C; 30 cycles, each cycle for 1 min, with a gradient temperature drop of 0.4°C; After 70 cycles, each cycle lasted 1 min, the temperature was gradually reduced by 0.8 °C; the temperature was kept constant at 22 °C for 30 min, and then placed in a 4 °C refrigerator for 1 h to obtain a TP solution; 2) DWD nucleic acid hybridization reaction: add 3 μL of 2 μM cholesterol nucleic acid chain, 1 μL of 2 μM DNAzyme and 1 μL of 2 μM Block chain to the 3 μL TP solution synthesized by PCR in step 1), mix well, centrifuge, react at room temperature for 1 hour to obtain DWD without substrate chain, add 2 μL of 2 μM substrate chain, mix well, centrifuge, react at room temperature for 1 hour to obtain DWD with substrate chain; 3) DNAzyme substrate cleavage reaction: DWD without substrate chain and DWD with substrate chain prepared in step 2) with a volume of 1 μL and a concentration of 2 μM were mixed with 2×10 5 After incubation at room temperature for 30 min, CEM cells were centrifuged at 1500 rpm for 3 min, the supernatant was removed, and 100 μL of PBS was resuspended. 20 nM miRNA122 strand, 2.5 mM Ca 2+ and 1.25 mM Mg 2+ , react at room temperature for 2 hours, and obtain DNA Walker nanomachines without substrate chains and DNA Walker nanomachines with substrate chains; 4) Hybridization chain synthesis nanowire reaction: 5 μL H1 and H2 were annealed to form a hairpin structure. The annealing procedure was as follows: 95°C for 10 min, then immediately placed in ice for 30 min, and finally placed at room temperature for 2 h. Then, 0.2 μM and 1 μL of the Trigger chain were added with 2 μM and 1 μL of H1, H2, H1-Sgc8, and H2-FAM, respectively, and mixed. The mixture was centrifuged and reacted at room temperature for 3 h to prepare a multivalent DNA nanowire with Trigger:H1:H2=1:10:10; 5) Logical nucleic acid chain hybridization reaction: The DNAWalker nanomachine with a volume of 1 μL and a concentration of 2 μM prepared in step 3) and 2×10 5 After incubating the CEM cells at room temperature for 30 min, centrifuge at 1500 rpm for 3 min, remove the supernatant, resuspend the cells in PBS to 100 μL, add 1 μL of 2 μM multivalent DNA nanowires prepared in step 4) that bind to H2-TCO1, H1-connect, and bind to H1-Sgc8, H2-connect, incubate the cells at room temperature for 30 min, centrifuge at 1500 rpm for 3 min, remove the supernatant, resuspend the cells in PBS to 100 μL, add 2 μM connect, 2.5 mM Ca 2+ and 1.25 mM Mg 2+ , react at 37℃ for 2h to detect tumor cell CEM and immune cell NK.
4. The method for preparing a multivalent DNA nanowire logic device coupled with a DNAWalker nanomachine for detecting membrane localized markers according to claim 2, It is characterized in that The DNA Walker nanomachine and the multivalent DNA nanowire present triangular prism and linear structures respectively, and have certain rheological properties, which are beneficial to the survival of cells.
5. Use of the multivalent DNA nanowire logic device coupled with a DNAWalker nanomachine for detecting membrane localized markers according to any one of claims 1 to 4 in the preparation of a kit for detecting miRNA122 released by liver damage.
6. Use of the multivalent DNA nanowire logic device coupled with a DNAWalker nanomachine for detecting membrane-localized markers according to any one of claims 1 to 4 in the preparation of a kit for specifically identifying and detecting tumor cells.
